Delivery Order SPE2DB24D2100-SPE2DB24FBDSF
Award Date
9/19/24
Potential Completion Date
9/20/24
Potential Value
$7.1K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $3,240.37 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of QULIPTA 60 MG TABLET 30S medication. The contract has a performance period ending on July 14, 2025 and is not designated as a set-aside. Amerisourcebergen Drug Corp is a critical vendor supporting federal medical procurement needs, particularly for military and veteran healthcare systems, through its substantial...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,617.28, is for the delivery of QULIPTA 60 MG TABLET 30S. The order has a period of performance through July 1, 2025 and is not designated as a set-aside. AmerisourceBergen Drug Corp holds a substantial $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $11,643.68 Firm Fixed Price delivery order is for the supply of QULIPTA 30 MG TABLET 30S, a pharmaceutical product. The contract has no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,152.36 firm fixed-price delivery order is for the supply of QULIPTA 60 MG TABLET 30S, a pharmaceutical product. The award is not associated with a set-aside program. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $25,264.39 firm-fixed-price delivery order is for the supply of QULIPTA 60 MG TABLET 30S, a pharmaceutical product, with a performance period through February 7, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,995.16 delivery order contract is for the supply of QULIPTA 60 MG TABLET 30S, a pharmaceutical product. The contract is not set aside and is a firm fixed-price type. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of QULIPTA 60 MG TABLET 30S, a medication, with a ceiling value of $28,102.43 and a completion date of June 30, 2025. The contract is a firm fixed-price delivery order with no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,817.06, is a delivery order for the medical product "QULIPTA 60 MG TABLET 30S" and has an ultimate completion date of March 14, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of QULIPTA 60 MG TABLET 30S. The $1,154.79 firm fixed-price contract has a completion date of July 11, 2025 and is not set aside for a specific business type. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a wide range of pharmaceutical...
This federal contract award was issued by the Defense Logistics Agency (DLA), a defense agency, to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,280.05 firm fixed price delivery order is for the supply of QULIPTA 60 MG TABLET 30S, a medication. The award is not designated as a set-aside contract. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...